Biotech

Biotech & Healthcare News

Biotech Healthcare Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Biotech

Top news of the week: 25.01.2022.

#clinicaltrials
#OBE
#Covid19
#Moderna
#biotech
#InnovationCup

Healthcare

@NatureBiotech shared
On Jan 23, 2022
RT @gstix1: What is on the leading edge of anti-aging research? Nobel-winning Yamanaka Factors, with support coming from Jeff Bezos and Yuri Milner. The big unresolved gamble: Will it make cells younger or just create tumors? The @naturebiotech story via @sciam https://t.co/MiB8ACqh3N
Open
Billionaires Bankroll Cell Rejuvenation Tech as the Latest Gambit to Slow Aging

Billionaires Bankroll Cell Rejuvenation Tech as the Latest Gambit to Slow Aging

Startups bet that carefully controlled cell reprogramming may lead to age reversal, but hurdles remain

@BIODeutschland shared
On Jan 25, 2022
RT @ITM_Radiopharma: ITM announces successful installation of our partner @Bruce_Power's new isotope production system for medical isotopes used in radiopharmaceutical cancer therapy. Read full press release here: https://t.co/ViJLUHvdRJ https://t.co/q4ztVvOaYz
Open
ITM: Installation of New Isotope Production System at Bruce Power to Produce Medical Isotopes for Cancer Therapy Completed

ITM: Installation of New Isotope Production System at Bruce Power to Produce Medical Isotopes for Cancer Therapy Completed

“Our medical Isotope Program and the IPS installation are a result of years of innovation and development in partnership with Isogen (a Framatome and Kinectrics company), Saugeen …

@BIODeutschland shared
On Jan 25, 2022
RT @Roche: We are pleased to announce the @FDA have granted priority review of the sNDA for our treatment for spinal muscular atrophy (SMA) in pre-symptomatic babies under 2 months of age https://t.co/xvullevW8Z https://t.co/cnHBf7smWw
Open
Roche’s Evrysdi (risdiplam) granted FDA priority review for treatment of pre-symptomatic babies under 2 months of age with spinal muscular atrophy (SMA)

Roche’s Evrysdi (risdiplam) granted FDA priority review for treatment of pre-symptomatic babies under 2 months of age with spinal muscular atrophy (SMA)

The sNDA submission incorporates interim data from the RAINBOWFISH study, which shows the majority of pre-symptomatic babies treated with Evrysdi achieved key milestones such as …

@MEDiSTRAVA_Cons shared
On Jan 25, 2022
Dr Melanie Ivarsson, OBE, has been appointed Non-Executive of the Board at @loqus23. Dr Ivarsson was awarded an #OBE in 2022 & led #clinicaltrials to develop one of the world’s first #Covid19 vaccines at #Moderna. Click for details: https://t.co/VCJaB171Jl https://t.co/ORlFq0dTpC
Open
LoQus23 Therapeutics appoints Dr. Melanie Ivarsson, OBE, as Non-Executive Director

LoQus23 Therapeutics appoints Dr. Melanie Ivarsson, OBE, as Non-Executive Director

/PRNewswire/ -- LoQus23 Therapeutics Ltd. ('LoQus23'), a biotech discovering small molecule therapies that target aberrant DNA mismatch repair (MMR) to treat...

@SWLifeSciences shared
On Jan 19, 2022
Biotech Could Launch Trial of Polyp Screening Test in March: https://t.co/idZdiC3pzK H.C. Wainwright & Co. has a Buy rating and a $3 per share price target on Check-Cap. $CHEK #biotech @CheckCap_ https://t.co/g1cdMjJ8VL
Open
Biotech Could Launch Trial of Polyp Screening Test in March Research Report

Biotech Could Launch Trial of Polyp Screening Test in March Research Report

The start of the C-Scan study would be a major milestone for Check-Cap, noted an H.C. Wainwright & Co. report.

@BIODeutschland shared
On Jan 25, 2022
RT @MerckHealthcare: 2 weeks left to apply to #InnovationCup 2022! Join a week-long camp to work together with other bright students in a highly stimulating environment. Open for postgraduate students with life sciences background. Apply until Jan 31st,2022! Learn more at 👉🏽 https://t.co/1OqRRxCq2v. https://t.co/UqIktoS7Cq
Open
Innovation Cup

Innovation Cup

Every year, we invite advanced students from all over the world to Darmstadt to participate in the Innovation Cup.

Read more: Healthcare
weekly 25.01.2022
View archives
Back to home

Subscribe to Biotech - Biotech & Healthcare.

Avoid an information overload and get the most trusted industry news hand-picked by the top Experts. Sign up for the weekly Biotech - Biotech & Healthcare.
Privacy Policy

Sign up for the weekly Biotech - Biotech & Healthcare newsletter

Never again miss anything or anyone that matter in Biotech

Sign up and receive the Biotech - Biotech & Healthcare weekly email newsletter directly to your inbox. Make more informed business decisions based on insight for the most trusted industry experts, faster.
Privacy Policy